Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients.

American journal of hematology - 1 Dec 2022

Lee Wan-Hsuan, Lin Chien-Chin, Tsai Cheng-Hong, Tseng Mei-Hsuan, Kuo Yuan-Yeh, Liu Ming-Chih, Tang Jih-Luh, Sun Hsun-I, Chuang Yi-Kuang, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fang

Abstract excerpt

Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal myeloid malignancies. Though several recurrent mutations are closely correlated with clinical outcomes, data concerning the association between mutation variant allele frequencies (VAF) and prognosis are limited. In this study, we performed comprehensive VAF analyses of relevant myeloid-malignancy related mutations in 698 MDS patients and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Prognosis

Share to Risk Assessment

Share to Splicing Factor U2AF

Source

Identifiers

PMID: 36109871
DOI: 10.1002/ajh.26734

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients.PMID 36109871Read ↗

Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes.Semantic proximity Read ↗

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.Semantic proximity Read ↗

Genetic and Clinical Features in TP53-Mutated Patients With Myelodysplastic Neoplasms: A Retrospective Study Based on Next-Generation Sequencing Data.Semantic proximity Read ↗

The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysis.Semantic proximity Read ↗

Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.Semantic proximity Read ↗

Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes.Semantic proximity Read ↗

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.Semantic proximity Read ↗

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes.Semantic proximity Read ↗

Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDSSemantic proximity Read ↗

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.Semantic proximity Read ↗

Clinical implications of variant allele frequencies of genes in patients with acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.